Literature DB >> 20375324

Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.

Ignasi Barba1, Marta Garcia-Ramírez, Cristina Hernández, María Angeles Alonso, Lluis Masmiquel, David García-Dorado, Rafael Simó.   

Abstract

PURPOSE: To explore the metabolic profile of vitreous fluid of patients with proliferative diabetic retinopathy (PDR) using 1H-NMR-based metabonomic analysis.
METHODS: 1H-NMR spectra were acquired from vitreous samples obtained during vitrectomy from 22 patients with type 1 diabetes with PDR and from 22 nondiabetic patients with macular hole (control group). Data analysis included a principal component analysis and partial least squares discriminant analysis (PLS-DA). In addition, 1H-(1)H and 1H-(13)C HMQC correlation spectra were acquired for the identification of metabolites. Furthermore, the main metabolites accounting for the differences in metabolic profile were assessed by current biochemical methods.
RESULTS: Lactate was the most abundant metabolite, and it was present at higher levels in samples from PDR patients than from nondiabetic patients (P=0.02). Glucose was significantly higher in samples from PDR patients than nondiabetic patients (P=0.03). After removing the lactate peak at 1.35 ppm and with the use of PLS-DA, a model was obtained that was able to correctly classify 19 of 22 patients with PDR and 18 of 22 controls, resulting in a sensitivity of 86% and a specificity of 81%. The main metabolites involved in this specific pattern recognition were galactitol and ascorbic acid (AA); levels of both were significantly lower in PDR patients.
CONCLUSIONS: 1H-NMR-based metabonomic analysis of vitreous fluid permits the obtainment of a metabolic signature of PDR. Apart from the higher abundance of lactate and glucose, significant deficits of galactitol and AA are the main metabolic fingerprints of vitreous fluid from PDR patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375324     DOI: 10.1167/iovs.10-5348

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  A critical assessment of feature selection methods for biomarker discovery in clinical proteomics.

Authors:  Christin Christin; Huub C J Hoefsloot; Age K Smilde; B Hoekman; Frank Suits; Rainer Bischoff; Peter Horvatovich
Journal:  Mol Cell Proteomics       Date:  2012-10-31       Impact factor: 5.911

Review 2.  Introduction to metabolomics and its applications in ophthalmology.

Authors:  S Z Tan; P Begley; G Mullard; K A Hollywood; P N Bishop
Journal:  Eye (Lond)       Date:  2016-03-18       Impact factor: 3.775

Review 3.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 4.  Metabolomics in diabetic complications.

Authors:  Laura A Filla; James L Edwards
Journal:  Mol Biosyst       Date:  2016-02-19

Review 5.  Metabolomics of Diabetic Retinopathy.

Authors:  Gerald Liew; Zhou Lei; Gavin Tan; Nichole Joachim; I-Van Ho; Tien Y Wong; Paul Mitchell; Bamini Gopinath; Ben Crossett
Journal:  Curr Diab Rep       Date:  2017-09-23       Impact factor: 4.810

Review 6.  Ascorbic acid repletion: A possible therapy for diabetic macular edema?

Authors:  James M May
Journal:  Free Radic Biol Med       Date:  2016-02-17       Impact factor: 7.376

7.  Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche.

Authors:  Zhiping Liu; Jiean Xu; Qian Ma; Xiaoyu Zhang; Qiuhua Yang; Lina Wang; Yapeng Cao; Zhimin Xu; Amany Tawfik; Ye Sun; Neal L Weintraub; David J Fulton; Mei Hong; Zheng Dong; Lois E H Smith; Ruth B Caldwell; Akrit Sodhi; Yuqing Huo
Journal:  Sci Transl Med       Date:  2020-08-05       Impact factor: 17.956

8.  Ascorbic acid prevents VEGF-induced increases in endothelial barrier permeability.

Authors:  Esad Ulker; William H Parker; Amita Raj; Zhi-chao Qu; James M May
Journal:  Mol Cell Biochem       Date:  2015-11-20       Impact factor: 3.396

Review 9.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

10.  Vitreous metabolomics profiling of proliferative diabetic retinopathy.

Authors:  Yohei Tomita; Gael Cagnone; Zhongjie Fu; Bertan Cakir; Yumi Kotoda; Masaki Asakage; Yoshihiro Wakabayashi; Ann Hellström; Jean-Sébastien Joyal; Saswata Talukdar; Lois E H Smith; Yoshihiko Usui
Journal:  Diabetologia       Date:  2020-10-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.